885675-75-2 Usage
Uses
Used in Oncology:
CMPT is used as an anticancer agent for its potential to treat both solid tumors and blood cancers. Its mechanism of action involves the inhibition of specific kinases that are crucial for cell growth and survival, thereby exhibiting antiproliferative effects on cancer cells.
Used in Pharmaceutical Development:
CMPT is utilized in the development of new pharmaceuticals targeting cancer treatment. Its unique chemical structure and demonstrated preclinical efficacy make it a promising candidate for further research to fully characterize its pharmacological and toxicological properties, with the aim of advancing its therapeutic potential.
Used in Drug Discovery:
In the field of drug discovery, CMPT serves as a lead compound for the development of novel therapeutic agents. Its structural features and biological activity provide a foundation for the design and synthesis of new molecules with improved potency, selectivity, and pharmacokinetic properties.
Used in Preclinical Research:
CMPT is employed in preclinical studies to evaluate its efficacy and safety in treating various types of cancer. These studies are essential for understanding the compound's mechanism of action, optimizing its formulation, and assessing its potential for clinical development.
Check Digit Verification of cas no
The CAS Registry Mumber 885675-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,6,7 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 885675-75:
(8*8)+(7*8)+(6*5)+(5*6)+(4*7)+(3*5)+(2*7)+(1*5)=242
242 % 10 = 2
So 885675-75-2 is a valid CAS Registry Number.
885675-75-2Relevant academic research and scientific papers
PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE
-
Page/Page column 158, (2008/12/06)
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R3 is a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. [Insert Formula Ic and Id]
